Table 1 Patient data and results of dapsone treatment for immune thrombocytopenia.
a)Patient remained on dapsone for 39.3 months. b)Response defined as platelet count ≥30×109/L and at least 2-fold increase over the baseline count and absence of bleeding.
Abbreviations: F, female; M, male; TPO-RA,thrombopoietin-receptor agonist.